Glucagon-Like Peptides and Uses Thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100009907A1
SERIAL NO

12302456

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to non-mammalian Glucagon-like peptides (nmGLP-1), analogs thereof, related nucleic acids, and processes production of such peptides. The nmGLP-1 peptides and analogs thereof of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent obesity, reducing body weight, controlling glycemia, controlling or reducing appetite, and reducing food intake.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMYLIN PHARMACEUTICALS INC9360 TOWNE CENTRE DRIVE SAN DIEGO CA 92121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Janssen, Samuel San Diego, US 9 407
Pittner, Richard A San Diego, US 17 654
Srivastava, Ved San Diego, US 11 443

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation